TP53 and breast carcinoma: In agreement with these findings, we observed a highly significant relationship between A3B expression and p53 mutational status in the METABRIC (P = 7.0 × 10−8) and TCGA (P = 2.2 × 10−16) breast cancer cohorts (Figure 1A).